SEC REGULATION D RULE 506(c) ACCREDITED MARKETPLACE

Litigation Syndication Deal Room

Direct allocation into single-case bankruptcy-remote Delaware SPVs. All deals pre-underwritten by FMC Actuarial Committee.

Investor Status

VERIFIED ACCREDITED

IP PATENT_INFRINGEMENTA+ • 88.4/100

Apex BioTherapeutics v. Meridian Pharma (Patent Infringement)

FMC Series SPV 2027-01 LLC (Delaware)

Target Raise

$1,500,000.00

Target Net IRR

24.5%

Min. Ticket

$50,000.00

Offering Deadline

2025-04-30

$1,250,000.00 Funded83%

COMMERCIAL CONTRACTA • 84.1/100

FMC Series SPV 2027-02 LLC (Delaware)

Target Raise

$2,200,000.00

Target Net IRR

22%

Min. Ticket

$100,000.00

Offering Deadline

2025-05-15

$1,100,000.00 Funded50%

CATASTROPHIC PIA+ • 89.7/100

FMC Series SPV 2027-03 LLC (Delaware)

Target Raise

$650,000.00

Target Net IRR

26%

Min. Ticket

$25,000.00

Offering Deadline

2025-03-31

$650,000.00 Funded100%